These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 29161205)
21. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma. Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475 [TBL] [Abstract][Full Text] [Related]
22. Increase in the rate of HPV positive oropharyngeal cancers during 1996-2011 in a case study in Turkey. Tural D; Elicin O; Batur S; Arslan D; Oz B; Serdengecti S; Uzel O Asian Pac J Cancer Prev; 2013; 14(10):6065-8. PubMed ID: 24289626 [TBL] [Abstract][Full Text] [Related]
23. Application of the Eighth Edition American Joint Committee on Cancer Staging System for HPV-Related Oropharyngeal Cancer Treated With Transoral Robotic Surgery. Badhey AK; Olson A; Kadakia S; Russo J; Ting P; Khalid M; Yao M; Teng MS; Genden EM; Miles BA; Chai RL Laryngoscope; 2018 May; 128(5):1133-1139. PubMed ID: 28990700 [TBL] [Abstract][Full Text] [Related]
24. Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: Relationship with human papillomavirus status and failure patterns. Huang YH; Yeh CH; Cheng NM; Lin CY; Wang HM; Ko SF; Toh CH; Yen TC; Liao CT; Ng SH PLoS One; 2017; 12(7):e0180779. PubMed ID: 28686646 [TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study. Sivars L; Landin D; Haeggblom L; Tertipis N; Grün N; Bersani C; Marklund L; Ghaderi M; Näsman A; Ramqvist T; Nordfors C; Munck-Wikland E; Tani E; Dalianis T Head Neck; 2017 Mar; 39(3):419-426. PubMed ID: 27898186 [TBL] [Abstract][Full Text] [Related]
26. HPV-positive head and neck tumours, a distinct clinical entity. Nevens D; Nuyts S B-ENT; 2015; 11(2):81-7. PubMed ID: 26563006 [TBL] [Abstract][Full Text] [Related]
27. Surrogate for oropharyngeal cancer HPV status in cancer database studies. Megwalu UC; Chen MM; Ma Y; Divi V Head Neck; 2017 Dec; 39(12):2494-2500. PubMed ID: 28963794 [TBL] [Abstract][Full Text] [Related]
28. The impact of HPV testing for oropharyngeal cancers: Why the addendum matters. Beadle BM Cancer Cytopathol; 2017 May; 125(5):301-302. PubMed ID: 28241100 [No Abstract] [Full Text] [Related]
29. [Changing trends in the management of the human papillomavirus induced oropharyngeal cancer]. Takácsi-Nagy Z Magy Onkol; 2018 Sep; 62(3):145-152. PubMed ID: 30256880 [TBL] [Abstract][Full Text] [Related]
30. Staging and treatment of oropharyngeal cancer in the human papillomavirus era. Ward MJ; Mellows T; Harris S; Webb A; Patel NN; Cox HJ; Piper K; Ottensmeier CH; Thomas GJ; King EV Head Neck; 2015 Jul; 37(7):1002-13. PubMed ID: 24753272 [TBL] [Abstract][Full Text] [Related]
31. Personalized Medicine and the Contradictions and Limits of First-Generation Deescalation Trials in Patients With Human Papillomavirus-Positive Oropharyngeal Cancer. Orlandi E; Licitra L JAMA Otolaryngol Head Neck Surg; 2018 Feb; 144(2):99-100. PubMed ID: 29167895 [No Abstract] [Full Text] [Related]
32. Implementing American Joint Committee on Cancer 8 Subramaniam N; Thankappan K; Anand A; Balasubramanian D; Iyer S Indian J Cancer; 2018; 55(1):4-8. PubMed ID: 30147086 [TBL] [Abstract][Full Text] [Related]
33. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer. Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358 [TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus-associated oropharyngeal cancer: a new clinical entity. Nguyen NP; Chi A; Nguyen LM; Ly BH; Karlsson U; Vinh-Hung V QJM; 2010 Apr; 103(4):229-36. PubMed ID: 20015950 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of human papillomavirus in oropharyngeal cancer: a multicenter study in Japan. Hama T; Tokumaru Y; Fujii M; Yane K; Okami K; Kato K; Masuda M; Mineta H; Nakashima T; Sugasawa M; Sakihama N; Yoshizaki T; Hanazawa T; Kato H; Hirano S; Imanishi Y; Kuratomi Y; Otsuki N; Ota I; Sugimoto T; Suzuki S Oncology; 2014; 87(3):173-82. PubMed ID: 25033838 [TBL] [Abstract][Full Text] [Related]
36. Predictive value of human papillomavirus in oropharyngeal carcinoma treated with radiotherapy: An updated systematic review and meta-analysis of 30 trials. Petrelli F; Sarti E; Barni S Head Neck; 2014 May; 36(5):750-9. PubMed ID: 23606404 [TBL] [Abstract][Full Text] [Related]
37. Population-based validation of the recursive partitioning analysis-based staging system for oropharyngeal cancer. Keane FK; Chen YH; Tishler RB; Schoenfeld JD; Haddad RI; Goguen LA; Catalano P; Neville BA; Margalit DN Head Neck; 2016 Oct; 38(10):1530-8. PubMed ID: 27080700 [TBL] [Abstract][Full Text] [Related]
39. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients. Smith RV; Schiff BA; Garg M; Haigentz M Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491 [TBL] [Abstract][Full Text] [Related]
40. The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer. Shaw R; Robinson M Br J Oral Maxillofac Surg; 2011 Sep; 49(6):423-9. PubMed ID: 20727631 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]